ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
This intro explains what a high index level may indicate in terms of trend strength, momentum, and potential market overheating.
25,925 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Fed minutes upend bets on easing, turning Bitcoin’s rate-cut narrative into a hike-risk problem as liquidity and poli...
MSTU, a 2x daily ETF linked to MSTR, has endured a brutal period as the underlying stock and crypto markets gyrate, s...
As copper markets gyrate in 2026, investors must choose between COPX miners and CPER futures for exposure. The decisi...
As summer kicks off, the 2027 cola calculation officially begins its data-driven cycle. Learn what to watch, how it a...
New BEA data show the fed’s favorite inflation gauge edging toward 3% for 2025, underscoring continued price pressure...
As volatility lingers into 2026, a three-rule framework offers a straightforward path to better risk-adjusted returns...
A little-known international ETF is quietly outperforming the S&P 500 this year, riding a multi-factor strategy and l...
A top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
A hypothetical turn of events places Kevin Warsh at the Fed helm, where rate cuts look unlikely as inflation remains ...
A new global study links warming to a sharp rise in extreme heat stress affecting about one billion more people. The ...
As Trump escalates public pressure on the Fed, new chair Warsh faces a test of independence. Markets swing while trad...